Brevan Howard Capital Management’s Immunome IMNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-31,878
Closed -$787K 1153
2024
Q1
$787K Buy
+31,878
New +$787K 0.01% 286